Search results
Regeneron (REGN) Outpaces Stock Market Gains: What You Should Know
Zacks via Yahoo Finance· 2 years agoRegeneron (REGN) closed at $587.28 in the latest trading session, marking a +0.2% move from the...
Regeneron (REGN) Soars 6.8%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 1 year agoRegeneron (REGN) witnessed a jump in share price last session on above-average trading volume. The...
Regeneron Pharmaceuticals' (NASDAQ:REGN) five-year total shareholder returns outpace the underlying...
Simply Wall St. via Yahoo Finance· 11 months agoWhile Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shareholders are probably generally happy, the...
Regeneron's (REGN) Lymphoma Candidate Rejected by the FDA
Zacks via Yahoo Finance· 2 months agoRegeneron Pharmaceuticals, Inc. REGN suffered a setback as the FDA issued Complete Response Letters...
Biotech Stock Roundup: REGN Down on Eylea Data, CINC Surges on AZN Offer & More
Zacks via Yahoo Finance· 1 year agoThe biotech sector was in focus with key pipeline and regulatory updates. Among these, Regeneron...
Regeneron (REGN) Accused of Fraudulent Practices Related to Eylea
Zacks via Yahoo Finance· 1 month agoShares of Regeneron Pharmaceuticals REGN were down 1.70% on Apr 11, following a complaint filed by...
An Intrinsic Calculation For Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Suggests It's 47%...
Simply Wall St. via Yahoo Finance· 1 month agoKey Insights Regeneron Pharmaceuticals' estimated fair value is US$1,774 based on 2 Stage Free Cash...
Regeneron (REGN) Gains But Lags Market: What You Should Know
Zacks via Yahoo Finance· 1 year agoRegeneron (REGN) closed at $729.91 in the latest trading session, marking a +1.1% move from the...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Could Be 29% Below Their Intrinsic Value...
Simply Wall St. via Yahoo Finance· 11 months agoKey Insights The projected fair value for Regeneron Pharmaceuticals is US$1,045 based on 2 Stage...